To announcement the Company to hold a material information
press conference on June 14, 2022
Date of events
2022/06/14
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/06/14
2.Company name:Bora Pharmaceuticals Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:The Company to hold a material information
press conference in Taipei Exchange at 19:30 on June 14, 2022
6.Countermeasures:After the press conference, the press release
will be issued through material information.
7.Any other matters that need to be specified:NA
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bora Pharmaceuticals Co. Ltd. published this content on 14 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2022 09:32:04 UTC.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
BORA PHARMACEUTICALS CO., LTD. 
